Table 1.
Distribution of study population across region of origin, with number of individuals, number of COVID-19 related ICU admissions and mortality, with unadjusted, and age and sex adjusted rates
| Region/country of birth | N(%) | COVID-19 mortality | COVID-19 mortality rate per 100,000 people | Age and sex standardized COVID-19 mortality rate per 100,000 people | COVID-19 ICU admission | COVID-19 ICU admission incidence rate per 100,000 people | Age and sex standardized COVID-19 ICU admission rate per 100,000 people |
|---|---|---|---|---|---|---|---|
| Sweden | 6,147,860 (78.2) | 15,063 | 110.5 (108.8–112.3) | 98.8 (97.2–100.4) | 5350 | 39.3 (38.2–40.3) | 37.5 (36.5–38.6) |
| Nordics w/o Sweden | 213,623 (2.7) | 1205 | 257.9 (243.4–272.5) | 144.5 (136.2–154.1) | 379 | 81.2 (73.0–89.4) | 56.9 (50.8–64.3) |
| EU28/EEA w/o Nordics | 327,230 (4.2) | 751 | 103.1 (95.7–110.5) | 121.6 (113.0–130.7) | 372 | 51.1 (45.9–56.3) | 60.8 (54.7–67.5) |
| Europe w/o EU28/EEA | 248,786 (3.2) | 603 | 108.7 (100.0–117.3) | 214.9 (197.0–234.2) | 616 | 111.1 (102.4–119.9) | 134.2 (123.1–146.6) |
| Middle East | 389,327 (5.0) | 590 | 67.6 (62.2–73.1) | 265.4 (241.8–291.1) | 1033 | 118.5 (111.3–125.8) | 177.8 (164.3–192.7) |
| Africa | 174,080 (2.2) | 193 | 49.4 (42.4–56.4) | 220.9 (182.4–268.5) | 358 | 91.8 (82.3–101.3) | 166.7 (143.7–197.5) |
| Asia | 253,705 (3.2) | 182 | 32.0 (27.3–36.6) | 193.2 (160.7–231.5) | 392 | 68.9 (62.1–75.7) | 157.2 (135.7–183.3) |
| North America | 24,832 (0.3) | 29 | 52.3 (33.3–71.4) | 68.4 (43.0–110.3) | 12 | 21.7 (9.4–33.9) | 27.5 (13.6–59.2) |
| South America | 77,713 (1.0) | 115 | 66.1 (54.0–78.1) | 167.1 (134.3–206.9) | 193 | 111.0 (95.4–126.7) | 137.3 (116.5–163.4) |